News from novartis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Sep 11, 2023, 13:00 ET Kesimpta entra no ROL da ANS. Pacientes adultos com a forma recorrente da esclerose múltipla, tratados com essa medicação durante estudo de extensão, tiveram taxa de surtos correspondente a um surto a cada 20 anos[i]

Oct 13, 2022, 15:34 ET 7 fatos que você precisa saber sobre a saúde do coração, por Novartis

Apr 05, 2022, 11:00 ET Doença que mata mais do que o câncer de mama pode ganhar nova terapia no SUS

Nov 26, 2021, 06:08 ET Novartis lance un pôle d'innovation virtuel pour accélérer les solutions de santé numérique en Afrique subsaharienne

Nov 25, 2021, 06:16 ET Novartis launches virtual innovation hub to accelerate digital health solutions in sub-Saharan Africa

Nov 25, 2021, 06:13 ET Novartis launches virtual innovation hub to accelerate digital health solutions in sub-Saharan Africa

Novartis has announced the launch of its new innovation hub, Novartis Biome sub-Saharan Africa (SSA), which will spearhead the further development of ...

Nov 01, 2021, 08:00 ET FDA approves Novartis Scemblix® (asciminib), with novel mechanism of action for the treatment of chronic myeloid leukemia

Novartis announced today that the US Food and Drug Administration (FDA) approved Scemblix® (asciminib) for the treatment of chronic myeloid leukemia...

Sep 30, 2021, 09:00 ET "Precisei vender meus bens e me mudar para ter acesso a tratamento", relata paciente de câncer de mama

Sep 17, 2021, 07:35 ET Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)

Novartis today announced important findings from a real-world study evaluating the safety and efficacy of alpelisib for people living with...

Sep 15, 2021, 14:50 ET Tenho câncer de mama, e agora? Tratamentos no SUS hoje atendem a apenas 20% dos casos

May 01, 2021, 07:05 ET Novartis Phase III BEOVU® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept

Novartis today announced positive one-year results of the Phase III KESTREL and KITE* studies, evaluating the efficacy and safety of BEOVU®...

Aug 27, 2020, 08:00 ET Novartis launches PsO in the Know podcast series hosted by music icon Cyndi Lauper

Novartis announced today, in honor of National Psoriasis (PsO) Awareness Month, Grammy, Tony, and Emmy award-winning singer, songwriter, actress, and ...

Aug 09, 2020, 15:12 ET Anvisa aprova o registro da primeira terapia gênica no Brasil

May 29, 2020, 08:01 ET Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery

Novartis announced today updated results from the landmark COMBI-AD clinical trial, demonstrating that treatment with Tafinlar® (dabrafenib) and...

May 27, 2020, 07:00 ET Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease

Novartis today announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, to be presented during the ASCO20...

May 14, 2020, 09:12 ET Novartis data at ASCO and EHA showcase bold approaches to reimagine cancer and blood disorders through multiple therapeutic platforms

Data from more than 110 abstracts, including Novartis-sponsored and investigator-initiated trials, will be presented during the upcoming American...

May 06, 2020, 14:38 ET Novartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14

Novartis announced today that the US Food and Drug Administration (FDA) approved Tabrecta™ (capmatinib, formerly INC280), an oral MET inhibitor for...

May 05, 2020, 06:00 ET Novartis apresenta proposta de inclusão de medicamento biológico para o tratamento da enxaqueca no rol da saúde suplementar

Mar 03, 2020, 07:52 ET Acesso a tratamento para câncer raro no sangue poderá ser ampliado no SUS, hoje cuidado é apenas paliativo

Jan 16, 2020, 03:00 ET Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People

Johnson & Johnson, Lilly, Novartis, Pfizer, GSK and the Bill & Melinda Gates Foundation have joined forces with Last Mile Health and Living Goods to...

Jan 02, 2020, 11:35 ET Governo avalia incorporação de medicamentos já disponíveis na rede privada para tratamento de câncer de pele agressivo no SUS

Nov 13, 2019, 08:00 ET Novartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace

Novartis announced today it has partnered with Grammy, Tony and Emmy award-winning singer, songwriter, actress and activist Cyndi Lauper to launch...